C-reactive protein and coronary events following percutaneous coronary angioplasty Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen,

Slides:

Advertisements

Similar presentations

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.

Advertisements

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

The “occasional open heart surgeon” revisited

Robert A. Guyton, MD The Annals of Thoracic Surgery

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms Martha M. Reigel,

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Introduction The American Journal of Medicine

Standardizing definitions for hybrid coronary revascularization

The present day potential role of fractional flow reserve–guided coronary artery bypass graft surgery Filip Casselman, MD, PhD, FETCS, Johan Van der.

Charles J. Mullany, MB, MS, Michael B

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies Ho Young Hwang, MD, Jin Hyun Kim, MD, Whal Lee,

Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results Alfredo Rodriguez,

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice? Yang Liu,

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients Hitoshi Hirose, MD, Atushi Amano, MD, Shuichirou Takanashi, MD, Akihito.

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Factors Influencing Mortality After Emergency Coronary Artery Bypass Grafting for Failed Percutaneous Transluminal Coronary Angioplasty Harold L Lazar,

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.

For everything there is a season

Perioperative cardiac events in endovascular repair of complex aortic aneurysms and association with preoperative studies Guilherme L. Bub, MD, Roy K.

To bypass or stent? The changing rules of an advancing game

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis.

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery Mark A. Hlatky, MD, David Shilane, PhD, Derek.

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Does Previous Percutaneous Coronary Stenting Compromise the Long-Term Efficacy of Subsequent Coronary Artery Bypass Surgery? A Microsimulation Study

Shengshou Hu, MD, Xin Yuan, MD, PhD

A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms Norman R. Hertzer, MD, Edward J. Mascha,

Coronary Revascularization on Balance: Robert L. Frye Lecture

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.

Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.

Does grafting of the left anterior descending artery with the in situ right internal thoracic artery have an impact on late outcomes in the context of.

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Sequential In Situ Left Internal Thoracic Artery Grafting to the Circumflex and Right Coronary Artery Areas Cihat Bakay, MD, Burak Onan, MD, Aşkin Ali.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis William.

Emergency surgery after unsuccessful coronary angioplasty: a review of 15 years’ experience Michael S Barakate, FRACS, Paul G Bannon, PhD, Clifford F.

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

C-reactive protein and coronary events following percutaneous coronary angioplasty Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen, Gerlind Heyde, MD, Matthijs Bax, MD, Carl E Schotborgh, MD, Karla J Mulder, Gerard T Sanders, PhD, Johan Fischer, PhD, Jan G.P Tijssen, PhD, Jan J Piek, MD, PhD The American Journal of Medicine Volume 115, Issue 2, Pages 85-90 (August 2003) DOI: 10.1016/S0002-9343(03)00238-9

Figure 1 Cumulative probability of death or nonfatal myocardial infarction (MI) following percutaneous coronary angioplasty, by C-reactive protein level (P <0.0001). The American Journal of Medicine 2003 115, 85-90DOI: (10.1016/S0002-9343(03)00238-9)

Figure 2 Cumulative probability of repeat revascularization (percutaneous transluminal angioplasty [PTCA] or coronary artery bypass graft [CABG] surgery) following percutaneous coronary angioplasty, by C-reactive protein level (P =0.24). The American Journal of Medicine 2003 115, 85-90DOI: (10.1016/S0002-9343(03)00238-9)